Timing of and risk factors for myocardial ischemic events after percutaneous coronary intervention (IMPACT-II)
- 1 February 2000
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 85 (4) , 427-434
- https://doi.org/10.1016/s0002-9149(99)00767-5
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Clinical risk factors for ischemic complications after percutaneous coronary interventions: Results from the EPIC trialAmerican Heart Journal, 1999
- Myonecrosis After Revascularization ProceduresJournal of the American College of Cardiology, 1998
- Does Intracoronary Thrombus Influence the Outcome of High Risk Percutaneous Transluminal Coronary Angioplasty? Clinical and Angiographic Outcomes in a Large Multicenter TrialJournal of the American College of Cardiology, 1998
- Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-IIThe Lancet, 1997
- Low-Normal or Excessive Body Mass Index: Newly Identified and Powerful Risk Factors for Death and Other Complications With Percutaneous Coronary InterventionThe American Journal of Cardiology, 1996
- Guidelines for percutaneous transluminal coronary angioplastyJournal of the American College of Cardiology, 1993
- Percutaneous Transluminal Coronary Angioplasty in New York StateJAMA, 1992
- Abrupt vessel closure complicating coronary angioplasty: Clinical, angiographic and therapeutic profileJournal of the American College of Cardiology, 1992
- Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group.Circulation, 1990
- Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty.Circulation, 1988